CLEVELAND, Dec. 14, 2012 (CRWENewswire)-- The Sherwin-Williams Company (NYSE:SHW) will issue a press release announcing its financial results for the fourth quarter and year ended December 31, 2012 prior to the opening of the …
In addition, Zacks Equity Research provides analysis onMylan Inc. (Nasdaq:MYL), Somaxon Pharmaceutical, Inc. …
SAN DIEGO--(BUSINESS WIRE)-- Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, 2011. “During the first quarter of 2011, …
BlackBerry addicts that keep strange hours should keep a stiff drink on hand between 2AM and 6AM EDT on Sunday, March 28th, because those are the hours RIM will be hard at work updating its North American servers to BIS 3.0. …
BGR1mon
Somaxon Pharmaceuticals (Nasdaq: SOMX) resubmitted its application to the Food and Drug Administration for its insomnia treatment Silenor with additional statistical analyses. The Food and Drug Administration approved Palomar …
Aug 20, 2009 04:18 PM U.S. Department of Justice Approves Oracle (ORCL) Acquisition of Sun (JAVA) Aug 7, 2009 10:58 AM EU identifies problem areas in Oracle's (ORCL), Sun (JAVA) takeover - Dow Jones Aug 4, 2009 12:54 PM Sun …
SAN DIEGO--(BUSINESS WIRE)-- Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company, today announced financial results for the quarter ended September 30, 2011. For the third quarter of 2011, …